Victoria P. Werth, M.D.
Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Department: Dermatology
Contact information
Division of Dermatology
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia, PA 19104
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia, PA 19104
Office: 215-823-4208
Fax: 215-823-5171
Fax: 215-823-5171
Education
M.S. (Physical Chemistry)
Catholic University, 1976.
B.A. (Chemistry)
Catholic University, 1976.
M.D. (Medicine)
Johns Hopkins University, 1980.
M.S. (Physical Chemistry)
Catholic University, 1976.
B.A. (Chemistry)
Catholic University, 1976.
M.D. (Medicine)
Johns Hopkins University, 1980.
Links
Scleroderma Foundation
Lupus Foundation of America
Medical Dermatology Society
International Pemphigus and Pemphigoid Foundation
The Myositis Association
Lupus Research Institute
Pennsylvania Academy of Dermatology
Philadelphia Dermatology Society
Scleroderma Foundation
Lupus Foundation of America
Medical Dermatology Society
International Pemphigus and Pemphigoid Foundation
The Myositis Association
Lupus Research Institute
Pennsylvania Academy of Dermatology
Philadelphia Dermatology Society
Post-Graduate Training
Intern in Medicine, Northwestern Memorial Hospital, Chicago, 1980-1981.
Resident in Internal Medicine, Northwestern Memorial Hospital, Chicago, 1981-1983.
Resident in Dermatology, New York University, 1983-1986.
Chief Resident in Dermatology, New York University, 1985-1986.
Research Fellow in Dermatology, New York University, 1986-1988.
Dermatology Foundation Fellow, New York University, 1987-1989.
Intern in Medicine, Northwestern Memorial Hospital, Chicago, 1980-1981.
Resident in Internal Medicine, Northwestern Memorial Hospital, Chicago, 1981-1983.
Resident in Dermatology, New York University, 1983-1986.
Chief Resident in Dermatology, New York University, 1985-1986.
Research Fellow in Dermatology, New York University, 1986-1988.
Dermatology Foundation Fellow, New York University, 1987-1989.
Certifications
American Board of Internal Medicine, 1983.
American Board of Dermatology, 1986.
American Boards of Immunodermatology and Immunopathology, 1989.
Permanent linkAmerican Board of Internal Medicine, 1983.
American Board of Dermatology, 1986.
American Boards of Immunodermatology and Immunopathology, 1989.
Description of Research Expertise
PhotobiologyTumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases
Description of Clinical Expertise
Autoimmune skin diseaseCutaneous Lupus Erythematosus
Dermatomyositis
Pemphigus vulgaris
Selected Publications
Saksena S, Yang X, Khosravi-Hafshejani T, Jun S, Wei E, Eldaboush A, Almeida Gomes LL, Feng R, Werth VP: Prednisone dosage is the primary modifiable risk factor for infection in pemphigus with rituximab treatment: A retrospective analysis of 105 patients. J Am Acad Dermato. J Am Acad Dermatol 95(4): 1208-1211, Oct 2026.Arkin LM, Buhr KA, Ardoin SP, Faith EF, Lee LW, von Scheven E, Brandling-Bennett JH, Castelo-Soccio L, Chiu YE, Diaz LZ, Garcia-Romero MT, Hunt RD, Oza VS, Schoch JJ, Paller AS, Vleugels RA, Chong BF, Werth VP, Ardalan K; CARRA-PeDRA Lupus Dermatology Work Groups: Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: results of a multicenter, retrospective cohort study. J Am Acad Dermatol 95(4): 1011-1019, Oct 2026.
Jun S, Gross N, Wei E, Saksena S, Eldaboush A, Homer RO, Almeida Gomes LL, Khosravi-Hafshejani T, Ali H, Werth VP: The association between family history of autoimmunity, herbal supplement use, and disease activity in dermatomyositis: A retrospective analysis. J Am Acad Dermatol 95(2): 566-568, Aug 2026.
Glen Aldrix R. Anarna, MD, Hanna Lucero-Orillaza, MD, Geraldine T. Zamora, MD, Blessie Marie B. Perez, MD, Victoria P. Werth, MD, Josef Symon S. Concha, MD: Evaluation of the Applicability of the Cutaneous Lupus Erythematosus Area and Severity Index (CLASI) in Filipino Cutaneous Lupus Erythematosus Patients. JAAD Int 27, Aug 2026.
Merola JF, Werth VP, Choi JC, Becker B, Edwards T, Hobar C, Pomponi S, Eliason L, Strand V: Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms. Lupus Sci Med 13(2), Jul 2026.
Han HS, Kulkarni R, Sollecito TP, Werth VP, Stoopler ET: Beyond 1993: A Case Illustrating the 2021 Revised Criteria for Paraneoplastic Autoimmune Multiorgan Syndrome. Int J Dermatol Jul 2026.
Jun S, Xie L, Lopes Almeida Gomes L, Saksena S, Wei E, Stone CJ, Forman Faden D, Yang X, Eldaboush A, Werth VP: Postural Orthostatic Tachycardia Syndrome and Dermatomyositis. JAMA Dermatol 162(9): 960-963, Jul 2026.
Morand EF, Werth VP, Wenzel J, Furie R, Dall'Era M, Sanchez-Guerrero J, Roy S, Goodson SG, Moreau F, Gühring H, Sgouroudi E, Klopp-Schulze L, Pearson DR: Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet Rheumatol 8(7): e513-e527, Jul 2026.
Dhiman R, Eldaboush A, Vijayarangan N, Kang D, Kodali N, Diaz D, Stone C, Feng R, Werth VP: The Effects of CB2R Activation on Inflammatory Pathways in Dermatomyositis. Biomedicines 14(6), Jun 2026.
Aggarwal R, Peeva E, Fiorentino DF, Vleugels RA, Mangold AR, Werth VP, Oemar BS, Rath JN, Sloan A, Chu M: Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study. Clin Cosmet Investig Dermatol 2026(19), Jun 2026.